iAnthus Capital Holdings (IAN.CN) Stock Analysis & Winston Score
iAnthus Capital Holdings is a cannabis company that grows, makes, and sells marijuana products across the United States. Its products include flower, vapes, edibles, and concentrates sold under brands like Leafly and Be. and MPX, targeting adult recreational and medical cannabis consumers. It operates dispensaries and production facilities in several US states, including Florida, New Jersey, and Massachusetts. iAnthus makes money by selling cannabis products directly to customers through its own retail dispensaries and through wholesale to other licensed stores. The company is mid-sized within the US cannabis sector, with operations concentrated in limited-license states where regulators cap the number of competitors, which provides some protection from unlimited competition. However, iAnthus has struggled with profitability, posting negative operating margins, and the continued federal illegality of cannabis in the US remains a significant risk — it restricts banking access, raises costs, and limits the company's ability to grow or raise capital efficiently.
Winston Score: 18/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (4/30)
- Growth: Weak (3/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
Key Facts
Price: 0.01 CAD
Market Cap: 35M CAD
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: Canadian Securities Exchange

